Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1998;82:244-250

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kodama, H.
Right arrow Articles by Ogawa, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kodama, H.
Right arrow Articles by Ogawa, S.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*L-TYROSINE
(Circulation Research. 1998;82:244-250.)
© 1998 American Heart Association, Inc.


Original Contributions

Biphasic Activation of the JAK/STAT Pathway by Angiotensin II in Rat Cardiomyocytes

Hiroaki Kodama, Keiichi Fukuda, Jing Pan, Shinji Makino, Motoaki Sano, Toshiyuki Takahashi, Shingo Hori, , Satoshi Ogawa

From the Cardiopulmonary Division (H.K., K.F., J.P., S.M., M.S., T.T., S.O.), Department of Internal Medicine, and the Department of Emergency Medicine (S.H.), Keio University, Tokyo, Japan.

Abstract—This study was designed to demonstrate the characteristic pattern of angiotensin II–induced JAK/STAT (indicating just another kinase/signal transducer and activator of transcription) activation in cultured rat cardiomyocytes by comparing it with leukemia inhibitory factor (LIF)-induced activation. Angiotensin II (10-7 mol/L) induced rapid phosphorylation of JAK2 and Tyk2, but not JAK1, and phosphorylated STAT1 and STAT2, but not STAT3, in the early stage up to 30 minutes. The time course of JAK/STAT activation by angiotensin II was apparently slower than that by LIF. Interestingly, angiotensin II phosphorylated STAT3 and rephosphorylated STAT1 in the late stage at 120 minutes. We also found that angiotensin II induced the formation of interferon-stimulating gene factor (ISGF) complexes biphasically, in the early stage at 15 to 30 minutes and in the late stage at 120 minutes, and that angiotensin II induced delayed activation of the sis-inducing factor (SIF) complex at 120 minutes. Formation of ISGF and SIF complexes in response to angiotensin II paralleled the phosphorylation pattern of STAT1 and STAT3 and was quite different from those obtained in response to LIF. The phosphorylation of STAT1 was suppressed by pretreatment with the angiotensin II type-1 (AT1) receptor antagonist CV11974, but the delayed addition of CV11974 failed to suppress phosphorylation of STAT3 at 120 minutes. In conclusion, angiotensin II–induced JAK/STAT activation in rat cardiomyocytes is biphasic and entirely different from LIF-induced activation.


Key Words: angiotensin II • cardiomyocyte • cardiac hypertrophy • JAK/STAT pathway • signal transduction




This article has been cited by other articles:


Home page
CirculationHome page
C.-T. Tsai, L.-P. Lai, K.-T. Kuo, J.-J. Hwang, C.-S. Hsieh, K.-L. Hsu, C.-D. Tseng, Y.-Z. Tseng, F.-T. Chiang, and J.-L. Lin
Angiotensin II Activates Signal Transducer and Activators of Transcription 3 via Rac1 in Atrial Myocytes and Fibroblasts: Implication for the Therapeutic Effect of Statin in Atrial Structural Remodeling
Circulation, January 22, 2008; 117(3): 344 - 355.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. Yang and L. A. Barouch
Leptin Signaling and Obesity: Cardiovascular Consequences
Circ. Res., September 14, 2007; 101(6): 545 - 559.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
K. E. Jie, M. C. Verhaar, M.-J. M. Cramer, K. van der Putten, C. A. J. M. Gaillard, P. A. Doevendans, H. A. Koomans, J. A. Joles, and B. Braam
Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectors
Am J Physiol Renal Physiol, November 1, 2006; 291(5): F932 - F944.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C.-H. Chen, T.-H. Cheng, H. Lin, N.-L. Shih, Y.-L. Chen, Y.-S. Chen, C.-F. Cheng, W.-S. Lian, T.-C. Meng, W.-T. Chiu, et al.
Reactive Oxygen Species Generation Is Involved in Epidermal Growth Factor Receptor Transactivation through the Transient Oxidization of Src Homology 2-Containing Tyrosine Phosphatase in Endothelin-1 Signaling Pathway in Rat Cardiac Fibroblasts
Mol. Pharmacol., April 1, 2006; 69(4): 1347 - 1355.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y. Itabashi, S. Miyoshi, S. Yuasa, J. Fujita, T. Shimizu, T. Okano, K. Fukuda, and S. Ogawa
Analysis of the electrophysiological properties and arrhythmias in directly contacted skeletal and cardiac muscle cell sheets
Cardiovasc Res, August 15, 2005; 67(3): 561 - 570.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. Modesti, I. Bertolozzi, T. Gamberi, M. Marchetta, C. Lumachi, M. Coppo, F. Moroni, T. Toscano, G. Lucchese, G. F. Gensini, et al.
Hyperglycemia Activates JAK2 Signaling Pathway in Human Failing Myocytes via Angiotensin II-Mediated Oxidative Stress
Diabetes, February 1, 2005; 54(2): 394 - 401.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Palm-Leis, U. S. Singh, B. S. Herbelin, G. D. Olsovsky, K. M. Baker, and J. Pan
Mitogen-activated Protein Kinases and Mitogen-activated Protein Kinase Phosphatases Mediate the Inhibitory Effects of All-trans Retinoic Acid on the Hypertrophic Growth of Cardiomyocytes
J. Biol. Chem., December 24, 2004; 279(52): 54905 - 54917.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F.-P. Xu, M.-S. Chen, Y.-Z. Wang, Q. Yi, S.-B. Lin, A. F. Chen, and J.-D. Luo
Leptin Induces Hypertrophy via Endothelin-1-Reactive Oxygen Species Pathway in Cultured Neonatal Rat Cardiomyocytes
Circulation, September 7, 2004; 110(10): 1269 - 1275.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
H.-C. Han, K. J. Austin, P. W. Nathanielsz, S. P. Ford, M. J. Nijland, and T. R. Hansen
Maternal nutrient restriction alters gene expression in the ovine fetal heart
J. Physiol., July 1, 2004; 558(1): 111 - 121.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
Y. Guo, E. Mascareno, and M. A. Q. Siddiqui
Distinct Components of Janus Kinase/Signal Transducer and Activator of Transcription Signaling Pathway Mediate the Regulation of Systemic and Tissue Localized Renin-Angiotensin System
Mol. Endocrinol., April 1, 2004; 18(4): 1033 - 1041.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
D. J. Lips, L. J. deWindt, D. J.W. van Kraaij, and P. A. Doevendans
Molecular determinants of myocardial hypertrophy and failure: alternative pathways for beneficial and maladaptive hypertrophy
Eur. Heart J., May 2, 2003; 24(10): 883 - 896.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. K. Podewski, D. Hilfiker-Kleiner, A. Hilfiker, H. Morawietz, A. Lichtenberg, K. C. Wollert, and H. Drexler
Alterations in Janus Kinase (JAK)-Signal Transducers and Activators of Transcription (STAT) Signaling in Patients With End-Stage Dilated Cardiomyopathy
Circulation, February 18, 2003; 107(6): 798 - 802.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. Pelletier, F. Duhamel, P. Coulombe, M. R. Popoff, and S. Meloche
Rho Family GTPases Are Required for Activation of Jak/STAT Signaling by G Protein-Coupled Receptors
Mol. Cell. Biol., February 15, 2003; 23(4): 1316 - 1333.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. A. Hall and R. J. Lefkowitz
Regulation of G Protein-Coupled Receptor Signaling by Scaffold Proteins
Circ. Res., October 18, 2002; 91(8): 672 - 680.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Li and P. E. Shaw
Autocrine-mediated Activation of STAT3 Correlates with Cell Proliferation in Breast Carcinoma Lines
J. Biol. Chem., May 10, 2002; 277(20): 17397 - 17405.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
G. D. Frank, S. Saito, E. D. Motley, T. Sasaki, M. Ohba, T. Kuroki, T. Inagami, and S. Eguchi
Requirement of Ca2+ and PKC{delta} for Janus Kinase 2 Activation by Angiotensin II: Involvement of PYK2
Mol. Endocrinol., February 1, 2002; 16(2): 367 - 377.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
R. M. Touyz and E. L. Schiffrin
Signal Transduction Mechanisms Mediating the Physiological and Pathophysiological Actions of Angiotensin II in Vascular Smooth Muscle Cells
Pharmacol. Rev., December 1, 2000; 52(4): 639 - 672.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Thibonnier, D. M. Conarty, and C. L. Plesnicher
Mediators of the mitogenic action of human V1 vascular vasopressin receptors
Am J Physiol Heart Circ Physiol, November 1, 2000; 279(5): H2529 - H2539.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Kodama, K. Fukuda, J. Pan, M. Sano, T. Takahashi, T. Kato, S. Makino, T. Manabe, M. Murata, and S. Ogawa
Significance of ERK cascade compared with JAK/STAT and PI3-K pathway in gp130-mediated cardiac hypertrophy
Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1635 - H1644.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
S. Kim and H. Iwao
Molecular and Cellular Mechanisms of Angiotensin II-Mediated Cardiovascular and Renal Diseases
Pharmacol. Rev., March 1, 2000; 52(1): 11 - 34.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. Takahashi, K. Fukuda, J. Pan, H. Kodama, M. Sano, S. Makino, T. Kato, T. Manabe, and S. Ogawa
Characterization of Insulin-Like Growth Factor-1-Induced Activation of the JAK/STAT Pathway in Rat Cardiomyocytes
Circ. Res., November 12, 1999; 85(10): 884 - 891.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. E. Dostal and K. M. Baker
The Cardiac Renin-Angiotensin System : Conceptual, or a Regulator of Cardiac Function?
Circ. Res., October 1, 1999; 85(7): 643 - 650.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. A. Hunt, G. J. Bhat, and K. M. Baker
Angiotensin II-Stimulated Induction of sis-Inducing Factor Is Mediated by Pertussis Toxin-Insensitive Gq Proteins in Cardiac Myocytes
Hypertension, October 1, 1999; 34(4): 603 - 608.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. C Wollert and H. Drexler
The renin-angiotensin system and experimental heart failure
Cardiovasc Res, September 1, 1999; 43(4): 838 - 849.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Dumler, A. Kopmann, K. Wagner, O. A. Mayboroda, U. Jerke, R. Dietz, H. Haller, and D. C. Gulba
Urokinase Induces Activation and Formation of Stat4 and Stat1-Stat2 Complexes in Human Vascular Smooth Muscle Cells
J. Biol. Chem., August 20, 1999; 274(34): 24059 - 24065.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Pan, K. Fukuda, M. Saito, J. Matsuzaki, H. Kodama, M. Sano, T. Takahashi, T. Kato, and S. Ogawa
Mechanical Stretch Activates the JAK/STAT Pathway in Rat Cardiomyocytes
Circ. Res., May 28, 1999; 84(10): 1127 - 1136.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. H. Sugden
Signaling in Myocardial Hypertrophy : Life After Calcineurin?
Circ. Res., April 2, 1999; 84(6): 633 - 646.
[Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. R. Simon, U. Rai, B. L. Fanburg, and B. H. Cochran
Activation of the JAK-STAT pathway by reactive oxygen species
Am J Physiol Cell Physiol, December 1, 1998; 275(6): C1640 - C1652.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. C. Venema, V. J. Venema, D. C. Eaton, and M. B. Marrero
Angiotensin II-induced Tyrosine Phosphorylation of Signal Transducers and Activators of Transcription 1 Is Regulated by Janus-activated Kinase 2 and Fyn Kinases and Mitogen-activated Protein Kinase Phosphatase 1
J. Biol. Chem., November 13, 1998; 273(46): 30795 - 30800.
[Abstract] [Full Text] [PDF]